scholarly journals Case – Endoscopic and endovascular management of inferior vena cava filter erosion into the right proximal ureter

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Natalie Jacox ◽  
Henry Han-I Yao ◽  
Ani Mirakhur ◽  
Darren Desantis
2017 ◽  
Vol 53 (2) ◽  
pp. 248-251 ◽  
Author(s):  
Bradley S. Jackson ◽  
Mykel Sepula ◽  
Jared T. Marx ◽  
Chad M. Cannon

2018 ◽  
Vol 2018 ◽  
pp. 1-3 ◽  
Author(s):  
Jeet J. Mehta ◽  
Benjamin DeMarco ◽  
John P. Vavalle ◽  
Khola S. Tahir ◽  
Joseph S. Rossi

A 73-year-old female presented with cardiogenic shock secondary to hemopericardium and cardiac tamponade. Imaging revealed two fractured legs of an inferior vena cava filter, with one leg within the anterior myocardium of the right ventricle and another penetrating the inferior septum through the middle cardiac vein. Hemopericardium and cardiac tamponade were treated with pericardiocentesis. A multidisciplinary meeting resulted in deferring further action against the embedded fractured legs of the filter with consideration of the patient’s age and comorbidities. This case report should alert clinicians to think about hemopericardium as a cause of cardiac tamponade and cardiogenic shock in a patient with a history of an inferior vena cava filter placement.


2017 ◽  
Vol 83 (9) ◽  
pp. 400-402
Author(s):  
Farzad Amiri ◽  
Ryan Landis ◽  
Paulina Skaff ◽  
David Denning ◽  
Constantinos Constantinou

2015 ◽  
Vol 2015 (mar06 1) ◽  
pp. bcr2014207865-bcr2014207865 ◽  
Author(s):  
A. Cusano ◽  
D. Rosenberg ◽  
P. Haddock ◽  
A. Meraney

Vascular ◽  
2005 ◽  
Vol 13 (5) ◽  
pp. 286-289 ◽  
Author(s):  
David Rosenthal ◽  
James L. Swischuk ◽  
Sidney A. Cohen ◽  
Eric D. Wellons

The purpose of this article is to describe our experience with the retrievable OptEase inferior vena cava filter (IVCF) (Cordis Corporation, Miami Lakes, FL) in the prevention of pulmonary embolus (PE). Forty patients (24 men, age range 15–85 years, mean age 38 years) who were at temporary risk of PE underwent insertion and retrieval of the OptEase IVCF at two institutions. Eleven patients were treated with filter implantation and subsequent repositioning in the inferior vena cava (IVC) to extend implantation time. All patients were followed up for 24 hours after retrieval, with additional follow-up at the physician's discretion. Forty patients had successful filter insertion. Two patients who underwent intravascular ultrasound guidance for filter deployment required filter repositioning within 24 hours owing to inadvertent placement in the right common iliac vein. All 40 patients underwent successful filter retrieval with no adverse events. In those patients who did not undergo IVCF repositioning, the time to retrieval ranged from 3 to 48 days (mean ± SD 16.38 ± 7.20 days). One patient had a successful retrieval at 48 days, but all other retrieval experiences were performed within 23 days. The second strategy involved implantation, with repositioning at least once before final retrieval. This latter strategy occurred in 11 patients, and the time to first capture ranged from 4 to 30 days (mean ± SD 13.82 ± 6.13 days). No symptomatic PE, IVC injury or stenosis, significant bleeding, filter fracture, or filter migration was observed. In this feasibility study, the OptEase IVCF prevented symptomatic PE, was safely retrieved or repositioned up to 48 days after implantation, and served as an effective bridge to anticoagulation. In patients who require extended IVCF placement, the OptEase IVCF can be successfully repositioned within the IVC, thereby extending the overall implantation time of this retrievable IVCF.


Vascular ◽  
2018 ◽  
Vol 26 (5) ◽  
pp. 483-489 ◽  
Author(s):  
Bernardino C Branco ◽  
Miguel F Montero-Baker ◽  
Eduardo Espinoza ◽  
Maria Gamero ◽  
Rodrigo Zea-Vera ◽  
...  

Objective Inferior vena cava occlusion is a potentially life-threatening complication related to caval filters. We present our experience with filter-induced inferior vena cava occlusion in order to assess the feasibility, safety, and effectiveness of endovascular management. Methods A retrospective review of all patients undergoing inferior vena cava filter placement over a 60-month study period was performed. From this cohort, a total of 10 cases of inferior vena cava occlusion after filter placement were identified. Demographics, clinical data, procedures, and outcomes were extracted. Patients were followed to the last clinic visit or until they died. Results One-hundred eighty filters were placed by our group practice during the study period. Of those, a total of 10 patients were identified. Overall, there were 7 males; the mean age was 57.1 years (25–78 years). The median time between inferior vena cava filter placement and filter occlusion was 105 days (range 5–4745 days). All patients were clinically symptomatic at the time of their presentation. Nine out of 10 patients were successfully managed endovascularly. Trellis™-8 thrombectomy was the most common endovascular strategy performed ( n = 9). Four patients had balloon angioplasty, two of those with stent placement for chronically occluded inferior vena cava/iliac veins. No thromboembolic complications developed during a median follow-up period of 233 days (range 4–1083 days). Conclusions Endovascular management of inferior vena cava occlusion is feasible, safe, and effective in decreasing thrombus burden in the presence of an inferior vena cava filter. Further studies evaluating long-term inferior vena cava patency and optimal surveillance regimen after endovascular management of filter-related inferior vena cava occlusion are warranted.


2018 ◽  
pp. bcr-2017-222054
Author(s):  
Zeyad Sako ◽  
Sindhu Reddy Avula ◽  
Elissa Gaies ◽  
Rebecca Daniel

Sign in / Sign up

Export Citation Format

Share Document